investing

Illumina Inc.

Analysts Ritholtz Wealth Management highlight Illumina (ILMN) as a biotech stock showing resilience amid market volatility

Illumina (ILMN) is experiencing a significant stock rebound, rising independently of broader market trends, which could signal a positive turnaround for the company after years of challenges. This resurgence is noteworthy for investors as it reflects both technical strength and improving fundamentals in the genomics sector.